首頁 > 市場調查報告書 > 醫療設備

透析設備

市場調查報告書

商品編碼

1439662

血液濃縮器 - 全球市場回顧、競爭格局、市場預測 (2030)

Hemoconcentrators - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年02月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

全球血液濃縮器市場規模預計到 2023 年將達到 1,163 萬美元，到 2030 年將達到 1,404 萬美元，2024-2030 年預測期間複合年增長率為 3.24%。由於心血管疾病負擔的增加、老年人口的增加、政府的舉措增多以及對提高血液濃縮器的安全性、可用性和易用性的日益關注等因素，血液濃縮器市場預計將增長。預測期內（ 2024-2030）的收入成長。

血液濃縮器市場動態

血液濃縮器市場的顯著驅動因素之一是心血管疾病盛行率的上升。

根據世界衛生組織 (WHO) (2022) 的數據，心血管疾病被認為是世界上最主要的死亡原因，每年影響約 1790 萬人的生命。需要搭橋手術的心血管疾病主要包括冠狀動脈疾病、主動脈瓣狹窄、水腫等疾病。

世界心臟聯盟（2019）的另一項研究估計，到 2030 年，全球將有超過 2,300 萬人受到心血管疾病的影響。

心血管疾病盛行率的增加可能與心血管疾病危險因子的增加有關，例如不健康的生活方式、吸菸、高血壓、糖尿病、飲酒和肥胖。

例如，根據健康指標與評估研究所（2023）的數據，2019 年全球吸菸者數量增加至 11 億，其中 90% 的新吸菸者在 25 歲時就開始上癮。

世界衛生組織 (2023) 的另一項有趣統計數據指出，從 1990 年到 2019 年，高血壓患者人數翻了一番，達到 12.8 億人。

上述風險因素的增加將增加未來幾年進行搭橋手術的需求，進而增加對血液濃縮器的需求。

此外，老年人口的增加更容易患心血管疾病，預計將進一步加速血液濃縮器市場的成長。根據世界衛生組織（2023）提供的數據，2020年，全球約有10億人年齡在60歲或以上。上述數據預測，到2050年，60歲以上老年人口將翻一番，達到約21億人。此外，預計 2020 年至 2050 年間，80 歲及以上的人口將增加兩倍，達到 4.26 億人。

因此，上述因素預計將加速血液濃縮器市場的成長。

然而，缺乏熟練的專業人員和手術期間的併發症可能是血液濃縮器市場的限制因素。

血液濃縮器市場預計將在最初幾個月受到影響，因為COVID-19 大流行導致封鎖、邊境關閉以及與血液濃縮器市場相關的活動（如製造、供應、進口和出口）的其他中斷。對增長產生輕微負面影響。此外，由於擔心 SARS-CoV-2 病毒（COVID-19 的病原體）的傳播以及大流行的不確定性，世界上許多國家都關閉了除緊急情況外的門診手術中心 (ASC)。被迫。然而，包括醫療產業在內的各行業活動的恢復正在推動血液濃縮器市場的發展，預計將在 2024 年至 2030 年的預測期內推動成長。

血液濃縮器細分市場分析

在血液濃縮器市場的產品類型細分中，兒科血液濃縮器類別在 2022 年佔最高收入佔有率，達到 71%。

患有心臟病的兒科患者數量不斷增加是兒科血液濃縮機增長的主要原因。根據 NHS (2022) 的數據，英國每 100 個嬰兒中就有 1 個出生時患有先天性心臟病。

根據美國疾病管制與預防中心 (2022) 的數據，大約四分之一的出生時患有心臟缺陷的嬰兒患有嚴重的先天性心臟病 (CHD)。

本報告研究和分析了全球血液濃縮器市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

血液濃縮器市場驅動因素
- 心血管疾病的盛行率和負擔不斷增加
- 全球人口老化負擔日益加重
- 各國政府的努力
血液濃縮器市場的限制與挑戰
- 缺乏熟練的專業人員
- 手術期間的併發症
血液濃縮器市場機遇
- 新興國家意識不斷提高帶來的成長機會
- 開發血液濃縮器的需求不斷增加

第 5 章血液濃縮器市場的波特五力分析

第6章COVID-19對血液濃縮機市場的影響分析

第7章血液濃縮器市場佈局

依產品類型
- 兒科血液濃縮器
- 成人血液濃縮器
按最終用戶
- 醫院
- 門診手術中心
按地區
- 北美
- 歐洲
- 亞太地區
- 其他領域

第 8 章血液濃縮器市場公司與產品概況

Getinge AB
LivaNova PLC
Braile Biomedica
Terumo Corporation
MEDICA S.P.A.
Andocor
NIPRO
STERIS
Chalice Medical Ltd.

第9章KOL瀏覽量

第 10 章專案方法

第 11 章關於 DelveInsight

第 12 章免責聲明與聯絡我們

簡介目錄圖表

Product Code: DIMDCL0501

Hemoconcentrators Market By Product Type (Pediatric Hemoconcentrators And Adult Hemoconcentrators), By End-User (Hospitals And Ambulatory Surgical Centres), and by geography is estimated to register a growth at a remarkable CAGR forecast during 2024-2030 owing to a surge in the cases of cardiovascular diseases and growing burden of geriatric population globally

The global hemoconcentrators market was valued at USD 11.63 million in 2023, growing at a CAGR of 3.24% during the forecast period from 2024 to 2030 to reach USD 14.04 million by 2030. The hemoconcentrators market is slated to witness growth owing to factors such as the rising burden of cardiovascular disorders, the rising geriatric population, the increasing number of government initiatives by countries, and the growing focus on improving the safety, affordability, and usability of hemoconcentrators is expected to result in appreciable revenue growth in the hemoconcentrators market during the forecast period (2024-2030).

Hemoconcentrators Market Dynamics:

One of the noteworthy drivers of the hemoconcentrators market is the rise in the prevalence of cardiovascular diseases.

As per the data provided by the World Health Organization (WHO) 2022, cardiovascular disorders are considered the leading cause of death worldwide affecting about 17.9 million lives every year. Cardiovascular diseases requiring bypass surgeries mainly include disorders such as coronary artery disease, aortic stenosis, and edema, among others.

In another study by the World Heart Federation in the year 2019, it had estimated that more than 23 million lives will be affected globally owing to cardiovascular disorders by the year 2030.

The increase in the rates of cardiovascular diseases can be linked to an increase in the risk factors for cardiovascular diseases such as unhealthy lifestyle, tobacco usage, hypertension, diabetes, alcohol consumption, obesity, and others.

For instance, according to the Institute for Health Metrics and Evaluation (2023), the number of smokers worldwide increased to 1.1 billion in 2019, where 90% of all new smokers became addicted by the age of 25.

Another interesting statistic by the WHO (2023), quoted that the number of people living with hypertension doubled to 1.28 billion from 1990-2019.

The increase in the abovementioned risk factors will increase the demand for more bypass surgeries to take place in the upcoming years, thus raising the demand for hemoconcentrators.

Additionally, the rising geriatric population prone to the development of cardiovascular diseases is further going to accelerate the growth of the hemoconcentrators market. According to the data provided by the WHO (2023), in 2020, about one billion people across the world were over the age of 60. The source mentioned above added by stating that by 2050, the elderly population aged 60 and above is expected to double in number representing about 2.1 billion people. Also, people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million.

Thereby, the above-mentioned factors are expected to accelerate the growth of the hemoconcentrators market.

However, the dearth of skilled professionals and complications during surgery may act as restraining factors for the hemoconcentrators market.

The COVID-19 pandemic had a slightly negative impact on the market growth of hemoconcentrators during the initial few months owing to the lockdown impositions, border closures, and others leading to the disruption in the manufacturing, supply, import, export, and other related activities of the hemoconcentrators market. Also, owing to the fear of the spread of the SARS-CoV-2 virus which is the causative agent for COVID-19, and uncertainties revolving around the pandemic, many countries across the world were forced to close down ambulatory surgical centers (ASCs) except in case of emergencies. However, the resumption of activities across industries including the healthcare sector has been uplifting the hemoconcentrators market and will drive growth during the forecast period from 2024-2030.

Hemoconcentrators Market Segment Analysis:

Hemoconcentrators Market by Product Type (Pediatric Hemoconcentrators and Adult Hemoconcentrators), End-user (Hospitals and Ambulatory Surgical Centres), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the hemoconcentrators market, the pediatric hemoconcentrators category held the highest revenue share of 71% in 2022.

The increasing number of pediatric patients with heart diseases is the main reason responsible for the growth of pediatric hemoconcentrators. According to NHS 2022, one in a hundred babies are born with congenital heart disease in the UK.

As per the Centers for Disease Control and Prevention, 2022, about 1 in 4 babies born with a heart defect have a critical congenital heart defect (CHD).

The increasing importance of pediatric coronary artery bypass surgery (PCABS) for congenital heart disease in infants and children undergoing modern cardiac surgical procedures, because of its life-saving potential in unsuccessful coronary transfer operations is going to increase the demand for pediatric hemoconcentrators.

Due to the small size and low weight of pediatric patients among other factors, performing bypass surgery in infants and neonates is complicated. Pediatric hemoconcentrators help in reducing inflammatory cytokines and correcting electrolyte and acid-base imbalances, limit early postoperative RBCs transfusions, reduces swelling of the heart, and facilitate the closing of surgical incision for better outcome of pediatric cardiac surgery.

For example, CAPIOX® HC05 Hemoconcentrators by Terumo Corporation is a type of pediatric Hemoconcentrator that efficiently concentrates blood using a polysulfone membrane material at a high ultrafiltration rate.

Therefore, owing to the above-mentioned factors the pediatric hemoconcentrators category is expected to witness substantial growth in the overall hemoconcentrators market during the given forecast period.

North America is expected to dominate the overall Hemoconcentrators Market:

Among all the regions, North America held the largest share of 45% in the hemoconcentrators market in 2022.

This domination is owing to the surging prevalence of cardiovascular disorders such as heart failure, congenital heart disease, hypertension, and others, the growing government initiatives in the cardiovascular sector in the United States, and the presence of key players in the region is expected to propel the overall market growth.

According to the latest study conducted by the Centres for Disease Control and Prevention (CDC), one person dies every 34 seconds in the United States from cardiovascular disease. Also, as per the same source, about 697,000 people in the United States died from heart disease in 2020, in the United States and about 20.1 million adults aged 20 and older had coronary artery disease (CAD). The mortality rate can be controlled by treating or managing the disease through surgical procedures such as cardiac bypass surgery, ultimately increasing the demand for hemoconcentrators.

As per the above-mentioned source, congenital heart defects are the most common type of birth defect in the United States, affecting nearly 1% (about 40,000) of births per year. The American Heart Association projected that by 2035, more than 130 million US adults will have some type of heart disease.

Moreover, the increasing prevalence of risk factors for cardiovascular diseases such as hypertension, obesity, age, arteriosclerosis, and others will in turn drive the market for hemoconcentrators. As per the source, Million Heart, 2022, high blood pressure is the most prevalent heart disease in the US, as almost half of the population had been diagnosed with hypertension, in 2020.

Therefore, the above-mentioned factors are going to bolster the North America hemoconcentrators markets.

Hemoconcentrators Market Key Players:

Some of the key market players operating in the Hemoconcentrators market include Getinge AB, LivaNova PLC, Braile Biomedica, Terumo Corporation, MEDICA S.P.A., Andocor, NIPRO, STERIS, Chalice Medical Ltd., and others.

Recent Developmental Activities in the Hemoconcentrators Market:

In June 2022, STERIS plc completed the acquisition of Cantel Medical which was the parent company of Medivators Inc. and Minntech, leading manufacturers of hemoconcentrators.

Key Takeaways from the Hemoconcentrators Market Report Study

Market size analysis for current hemoconcentrators market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the hemoconcentrators market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years.

Key companies dominating the global hemoconcentrators market.

Various opportunities available for the other competitor in the hemoconcentrators market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current hemoconcentrators market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for hemoconcentrators market growth in the coming future?

Target Audience who can be benefited from this Hemoconcentrators Market Report Study

Hemoconcentrators providers

Research organizations and consulting companies

Hemoconcentrators -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in hemoconcentrators

Various end users who want to know more about the hemoconcentrators market and the latest technological developments in the hemoconcentrators market.

Frequently Asked Questions for the Hemoconcentrators Market:

1. What are hemoconcentrators?

A hemoconcentrator is an ultrafiltration device consisting of semipermeable membrane fibers that remove plasma water and solutes. Blood passes through fibers of a microporous membrane, and since the hydrostatic pressure inside the fibers is higher than outside, effluent fluid can pass through the membrane and be drained.

2. What is the market for global hemoconcentrators?

The global hemoconcentrators market was valued at USD 11.63 million in 2023, growing at a CAGR of 3.24% during the forecast period from 2024 to 2030 to reach USD 14.04 million by 2030.

3. What are the drivers for the global hemoconcentrators market?

The hemoconcentrators market is expected to grow significantly owing to factors such as the rising burden of cardiovascular disorders, the rising geriatric population, and the increasing number of government initiatives by countries, among others during the given forecast period (2024-2030).

4. Who are the key players operating in the global hemoconcentrators market?

Some of the key market players operating in the hemoconcentrators market include Getinge AB, LivaNova PLC, Braile Biomedica, Terumo Corporation, MEDICA S.P.A., Andocor, NIPRO, STERIS, Chalice Medical Ltd., and others.

5. Which region has the highest share in the hemoconcentrators market?

North America is expected to dominate the overall hemoconcentrators market during the forecast period, 2024 to 2030. This can be ascribed to the presence of a large number of people suffering from cardiovascular diseases along with the rising geriatric population in the region. In addition, it is a highly potent market in terms of technological developments and launches along with the presence of key market players among other factors in the region.

1.Hemoconcentrators Market Report Introduction

2. Hemoconcentrators Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Hemoconcentrators Market Key Factors Analysis

4.1. Hemoconcentrators Market Drivers
- 4.1.1. Increase in the prevalence and burden of cardiovascular diseases
- 4.1.2. The escalating burden of the geriatric population globally
- 4.1.3. Government initiatives by the countries
4.2. Hemoconcentrators Market Restraints and Challenges
- 4.2.1. The dearth of skilled professionals
- 4.2.2. Complications during surgery
4.3. Hemoconcentrators Market Opportunities
- 4.3.1. Growth opportunities in emerging countries owing to rising awareness
- 4.3.2. Rising need to develop hemoconcentrators

5. Hemoconcentrators Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Hemoconcentrators Market

7. Hemoconcentrators Market Layout

7.1. By Product Type:
- 7.1.1. Pediatric Hemoconcentrators
- 7.1.2. Adult Hemoconcentrators
7.2 By End User
- 7.2.1. Hospitals
- 7.2.2. Ambulatory Surgical Centres
7.3. By Geography
- 7.3.1. North America
  - 7.3.1.1. United States Hemoconcentrators Market in USD million (2021-2030)
  - 7.3.1.2. Canada Hemoconcentrators Market in USD million (2021-2030)
  - 7.3.1.3. Mexico Hemoconcentrators Market in USD million (2021-2030)
- 7.3.2. Europe
  - 7.3.2.1. France Hemoconcentrators Market in USD million (2021-2030)
  - 7.3.2.2. Germany Hemoconcentrators Market in USD million (2021-2030)
  - 7.3.2.3. United Kingdom Hemoconcentrators Market in USD million (2021-2030)
  - 7.3.2.4. Italy Hemoconcentrators Market in USD million (2021-2030)
  - 7.3.2.5. Spain Hemoconcentrators Market in USD million (2021-2030)
  - 7.3.2.6. Rest of Europe Hemoconcentrators Market in USD million (2021-2030)
- 7.3.3. Asia-Pacific
  - 7.3.3.1. China Hemoconcentrators Market in USD million (2021-2030)
  - 7.3.3.2. Japan Hemoconcentrators Market in USD million (2021-2030)
  - 7.3.3.3. India Hemoconcentrators Market in USD million (2021-2030)
  - 7.3.3.4. Australia Hemoconcentrators Market in USD million (2021-2030)
  - 7.3.3.5. South Korea Hemoconcentrators Market in USD million (2021-2030)
  - 7.3.3.6. Rest of Asia Pacific Hemoconcentrators Market in USD million (2021-2030)
- 7.3.4. Rest of the World (RoW)
  - 7.3.4.1. Middle East Hemoconcentrators Market in USD million (2021-2030)
  - 7.3.4.2. Africa Hemoconcentrators Market in USD million (2021-2030)
  - 7.3.4.3. South America Hemoconcentrators Market in USD million (2021-2030)

8. Hemoconcentrators Market Company and Product Profiles

8.1. Getinge AB
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. LivaNova PLC
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Braile Biomedica
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. Terumo Corporation
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. MEDICA S.P.A.
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. Andocor
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. NIPRO
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. STERIS
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Chalice Medical Ltd.
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy